| Target Price | $389.64 |
| Price | $313.22 |
| Potential | 24.40% |
| Number of Estimates | 28 |
| 28 Analysts have issued a price target American Express 2027 . The average American Express target price is $389.64. This is 24.40% higher than the current stock price. The highest price target is $472.50 50.85% , the lowest is $332.29 6.09% . | |
| A rating was issued by 37 analysts: 20 Analysts recommend American Express to buy, 16 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the American Express stock has an average upside potential 2027 of 24.40% . Most analysts recommend the American Express stock at Purchase. |
29 Analysts have issued a sales forecast American Express 2026 . The average American Express sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
3 Analysts have issued an American Express EBITDA forecast 2026. The average American Express EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
33 American Express Analysts have issued a net profit forecast 2026. The average American Express net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
American Express...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 12 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 12 2026 |
| BMO Capital |
➜
Outperform
|
Initiated | Oct 09 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 09 2026 |
| TD Cowen |
Hold
➜
Hold
|
Unchanged | Oct 06 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 05 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 05 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 12 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 12 2026 |
|
Initiated
BMO Capital:
➜
Outperform
|
Oct 09 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 09 2026 |
|
Unchanged
TD Cowen:
Hold
➜
Hold
|
Oct 06 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 05 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 05 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


